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Abstract The non-cancer mortality data for cerebrovas-
cular disease (CVD) and cardiovascular diseases from
Report 13 on the atomic bomb survivors published by the
Radiation Effects Research Foundation were analysed to
investigate the dose–response for the inﬂuence of radiation
on these detrimental health effects. Various parametric and
categorical models (such as linear-no-threshold (LNT) and
a number of threshold and step models) were analysed with
a statistical selection protocol that rated the model
description of the data. Instead of applying the usual
approach of identifying one preferred model for each data
set, a set of plausible models was applied, and a sub-set of
non-nested models was identiﬁed that all ﬁtted the data
about equally well. Subsequently, this sub-set of non-nes-
ted models was used to perform multi-model inference
(MMI), an innovative method of mathematically combin-
ing different models to allow risk estimates to be based on
several plausible dose–response models rather than just
relying on a single model of choice. This procedure thereby
produces more reliable risk estimates based on a more
comprehensive appraisal of model uncertainties. For CVD,
MMI yielded a weak dose–response (with a risk estimate of
about one-third of the LNT model) below a step at 0.6 Gy
and a stronger dose–response at higher doses. The calcu-
lated risk estimates are consistent with zero risk below this
threshold-dose. For mortalities related to cardiovascular
diseases, an LNT-type dose–response was found with risk
estimates consistent with zero risk below 2.2 Gy based on
90% conﬁdence intervals. The MMI approach described
here resolves a dilemma in practical radiation protection
when one is forced to select between models with pro-
foundly different dose–responses for risk estimates.
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Introduction
One of the most important questions in radiation research
relates to the shape of the dose–response for detrimental
health effects at low doses, that is, whether any small dose
of ionizing radiation adds to health risks, or whether there
may be a threshold below which radiation may have no
effect, or whether even protective effects may occur
(Brenner et al. 2003; Averbeck 2009). This question bears
essential relevance for our societies given, for example, the
widespread use of medical imaging techniques such as CT
scans, X-ray images, and mammography. It is also relevant
for air crews and large worker populations who are
exposed occupationally, for example, in nuclear installa-
tions. The possible risks of ionizing radiation are not lim-
ited to cancer but also relate to non-cancer diseases (Little
et al. 2010). In that context, the question of a possible
threshold or protective effects at low and/or medium doses
is equally important as it is for cancer (Preston et al. 2003;
Shimizu et al. 2010).
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DOI 10.1007/s00411-012-0410-4The mortality data from the Life Span Study (LSS),
relating to the A-bomb survivors in Hiroshima and Naga-
saki, are generally considered to be important for esti-
mating the risk associated with ionizing radiation. Analyses
of these data suggest a role of ionizing radiation in the
formation of non-cancer diseases such as cerebrovascular
disease (CVD)
1 and cardiovascular diseases excluding
CVD
2 (Preston et al. 2003). Preston et al. (2003) concluded
that the evidence for radiation effects on non-cancer mor-
tality remains strong, with risks elevated by about 14% per
Sv during the last 13 years of follow-up and that the best
estimate for a threshold-dose is 0.2 Sv with an upper bound
of about 0.7 Sv with no evidence against the linear-no-
threshold hypothesis.
For protracted exposures, an important data set is the
Mayak worker cohort (Azizova et al. 2008). The Mayak
workers were exposed to low and medium doses at low
dose rates. This together with the fact that these individuals
did not have the threatening and traumatic experience of
being exposed to the detonation of a nuclear bomb makes
this data set especially valuable for risk estimations of
general populations. Recently, statistically signiﬁcant
increasing trends in the incidence of cardiovascular and
cerebrovascular diseases with external c-ray dose have
been reported for this cohort (Azizova et al. 2010a, b,
2011). Azizova et al. (2010a) found statistically signiﬁcant
increasing trends with both total external gamma-ray dose
and internal liver dose in the incidence of ischaemic heart
disease, a form of cardiovascular disease. They also
reported statistically signiﬁcant increasing trends in cere-
brovascular disease incidence but not mortality with both
total external c-ray dose and internal liver dose from
a-particle radiation (Azizova et al. 2010b, 2011).
In an extensive review, Little et al. (2010) present evi-
dence for the epidemiological associations between lower-
dose exposures and circulatory disease risks. They
reviewed epidemiological data related to the atomic bomb
survivors, low- and moderate-dose therapeutically exposed
groups, and diagnostically, occupationally, and environ-
mentally exposed groups. The authors conclude that the
epidemiological evidence for an elevation of these diseases
by moderate and low doses remains suggestive rather than
persuasive (Little et al. 2010).
In the current study, various plausible dose–response
curves (such as linear-no-threshold (LNT), linear quadratic,
linear with threshold, step functions, hormesis-like dose–
responses) were applied to the LSS data for CVD and
cardiovascular diseases excluding CVD from Report 13
(Preston et al. 2003), and suitable quality-of-ﬁt criteria
were used to select the preferred models. A series of
likelihood-ratio tests was used to obtain a set of preferable
non-nested models. Multi-model inference (MMI), an
innovative method to combine the estimates of several
plausible non-nested models (Burnham and Anderson
2002; Claeskens and Hjort 2008), was then applied. The
method resulted in a joint dose–response for each of the
two biological endpoints. In the ﬁeld of radiation epide-
miology, MMI poses a fascinating new approach that
avoids the danger of producing biased results from relying
on just one single model of choice. Before the MMI
method was introduced to radiation epidemiology by
Walsh and Kaiser (2011), there was an earlier proposal to
combine different probability distributions by assigning
different probabilities to them regarding the possible
existence of low-dose thresholds (Land 2002). This con-
cept of Land (2002) can be regarded as a stimulating
suggestion to apply MMI. For a further discussion of model
selection criteria in radiation epidemiology, see the study
by Walsh (2007).
An analysis of a more recent LSS data set with follow-
up from 1950 to 2003 has also been performed (Shimizu
et al. 2010). However, the question whether the dose–
response is linear at low doses without threshold or whe-
ther nonlinear dose–response features are present is still
unresolved. In the present study, it is shown that the shape
of the dose–response curve cannot be found by exclusively
using either the LNT or the linear threshold model, the
approach used by Shimizu et al. (2010). The fact that
several risk models yield plausible ﬁts to the data is duly
considered and accounted for here.
Materials and methods
Data on non-cancer disease mortality
The present analyses are based on two data sets for cere-
brovascular disease (CVD; ICD-9 430–438) and cardio-
vascular diseases excluding CVD (ICD-9 390–429,
440–459) of LSS Report 13 (Preston et al. 2003; data
ﬁleR13MORT.DAT from http://www.rerf.or.jp). In the
remainder of this publication, the ICD-9 codes 390–429,
440–459 are simply referred to as cardiovascular diseases.
In the ﬁle R13MORT.DAT, the data are provided in a
person-year table and are categorized by city, sex, age at
exposure, age attained, calendar time period during which
1 It is noted that Preston et al. (2003) and Shimizu et al. (2010) refer
to the ICD-9 codes 430–438 as ‘‘stroke’’, while stroke is in fact a
subgroup of ICD-9 430–438. The latter represents cerebrovascular
disease.
2 It is noted that Preston et al. (2003) and Shimizu et al. (2010) refer
to the ICD-9 codes 390–429, 440–459 as ‘‘heart disease’’, while these
ICD-9 codes are better described as cardiovascular diseases excluding
CVD (Dr. Frauke Neff, Helmholtz Zentrum Mu ¨nchen, personal
communication).
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123the mortality checks were made, and weighted survivor
colon dose. For each data group, the data ﬁle contains
person-year weighted means of age attained, age at expo-
sure, colon dose with a weight of ten for the neutron
contribution, the number of person-years, and the number
of deaths cases.
The data were analysed with exactly the same restric-
tions applied by Preston et al. (2003): we used data with
follow-up starting on 1 January 1968 and ending on 31
December 1997. Only proximal survivors were taken
where proximal is taken to mean survivors who were
within a radius of 3 km from the hypocenter at the time of
bombing. That gives 50,364 individuals (19,467 men and
30,897 women), of whom 3,954 died from CVD (1,434
men and 2,520 women) and 4,477 died from cardiovascular
diseases (1,614 men and 2,863 women). The number of
person-years is 1200,991.8 (452,161.6 and 748,830.2 per-
son-years for men and women, respectively). Data per-
taining to men and women were ﬁtted jointly.
Descriptive risk models
The mortality data for CVD and cardiovascular diseases
from Report 13 of the LSS were analysed with the following
parametric and categorical models for the risk that stems
from radiation: the LNT model, the quadratic model and the
linear-quadratic model, the linear-exponential model, the
linear threshold model (often referred to as threshold model
within this study), various step models, hormesis-like
models and one categorical model. Altogether, eleven dif-
ferent dose–responses were tested (Fig. 1). All of them were
implemented either as excess relative risk (ERR) models or
as excess absolute risk (EAR) models. The general form of
an ERR model is as follows: h = h0 9 (1 ? ERR(D, s, a,
e)) where h is the total hazard function, h0 is the baseline
model and the function ERR(D, s, a, e) describes the change
of the hazard function with weighted colon dose D allowing
for effects of sex (s), age at exposure (e) and attained age
(a). It is ERR(D, s, a, e) = err(D) 9 e(s, a, e). Here,
err(D) describes the shape of the dose–response function
and e(s, a, e) contains the dose-effect modiﬁers sex, age
attained, and age at exposure. The general form of an EAR
model is h = h0 ? EAR(D, s, a, e) where EAR(D, s, a,
e) = ear(D) 9 e(s, a, e). Mathematical details related to the
effect modiﬁers are given in Sect. 3 of the Online Resource.
For h0, we ﬁrst applied the Preston baseline model given
in Eq. (A1) of the Online Resource (see ﬁle R13models.log
at http://www.rerf.or.jp/library/dl_e/lss13.html, Preston et al.
(2003)).
For err(D) and ear(D) the following dose–response
models were used:
err D ðÞ ¼ err   D LNT model; #1 in Fig:1
err D ðÞ ¼ 1:12 err  D2 Quadratic model; #2 in Fig:1
err D ðÞ ¼ err1   D þ 1:12   err2   D2
Linear - quadr: model; #3 in Fig:1
err D ðÞ ¼err1 þ err2D ðÞ   exp  err3D2   
Linear - expon: model; #4 in Fig:1
errðDÞ¼
0 D\Dth
errðD   DthÞ D Dth
  
Linear thresh: model; #5 in Fig:1
err D ðÞ ¼ 0:5   scale   tanh sD  Dth ðÞ ðÞ þ 1 ½ 
Step model; #6 in Fig:1
errðDÞ¼ 0 D\Dth
err   DD  Dth
  
Step model with slope; #7 in Fig:1
errðDÞ¼ 0 D\Dth
err1 þ err2ðD   DthÞ D Dth
  
Step model with slope; #8 in Fig:1
errðDÞ¼
0 D\0:005Gy
err1 0:005Gy D\Dth
err2 D Dth
8
<
:
9
=
;
Hormesis - like model; #9 in Fig:1
errðDÞ¼
0 D\0:005Gy
err1 0:005Gy D\Dth
err1 þ err2ðD   DthÞ D Dth
8
<
:
9
=
;
Hormesis - like withslope; #10 in Fig:1
errðDÞ¼
err1 0 D\D1
err2 D1  D\D2
err3 D2  D\D3
err4 D D3
8
> > <
> > :
9
> > =
> > ;
3 - step categorical model; #11
The necessary adjustments for random errors in
dosimetry applied to the dose term are already applied in
the publicly available data, but a separate adjustment
involving a multiplication factor to the dose-squared
covariable should be done explicitly, either according to
Pierce et al. (1990) (factor 1.12) or Pierce et al. (2008)
(revised factor 1.15). Since most of the published analyses
apply the factor 1.12, this has been adopted here for the
quadratic and linear-quadratic models.
The Preston baseline model (given in Eq. (A1) of the
Online Resource) was optimized here with series of like-
lihood-ratio tests. For nested models, the difference
between their deviances (dev) is v
2-distributed (Claeskens
and Hjort 2008). A model is considered an improvement
over another model with a 95% probability if the deviance
is lowered by at least 3.84 points after adding of one
parameter. A description of this streamlining process,
Radiat Environ Biophys (2012) 51:165–178 167
123which has also been applied in a recent study on breast
cancer risk in atomic bomb survivors (Kaiser et al. 2011),
is given below.
Streamlining the Preston baseline model
Preston’s ﬁt to the LSS data for CVD (presented in
Table 13 in Preston et al. (2003)) was reproduced in the
ﬁrst step. Preston et al. (2003) concluded that an LNT
model implemented as ERR model ﬁtted the data best. In
order to reproduce this, the Preston baseline model given in
Eq. (A1) of the Online Resource was combined with an
LNT model, implemented as an ERR model and ﬁtted to
the joint data for CVD in men and women. This model is
referred to as Preston’s ERR-LNT model and contains 30
model parameters (dev = 3599.58, Table 1). Then, each of
the 29 baseline parameters was tested for its signiﬁcance at
the 95% signiﬁcance level by setting it to 0 and reﬁtting
all the other parameters. Rigorous testing led to a new set
of statistically signiﬁcant baseline parameters, with eight
parameters less than Preston et al. (2003) used within their
baseline model [h0 from Eq. (A1)]: the new model no
longer contained four age at exposure dependences, the
related three age knots, and one age attained dependence.
In addition, it was found that the model ﬁt signiﬁcantly
improved when two other age knots and one age at expo-
sure knot were allowed to be free (for details consult
Sect. 2 of the Online Resource). The streamlined baseline
model for CVD, which was used in combination with the
11 models depicted in Fig. 1, therefore has 21 (29 - 8)
model parameters (see Table S1 in the Online Resource).
For cardiovascular diseases, an analogous procedure
was applied. Preston’s best ﬁt of the data for cardiovascular
diseases was reproduced: the Preston baseline model given
in Eq. (A1) of the Online Resource was combined with an
LNT model, implemented as ERR model and ﬁtted to the
joint data for cardiovascular diseases. The results of ﬁtting
Preston’s ERR-LNT model are given in Table 1:
dev = 3709.71 with 30 model parameters. Then, each of
the 29 baseline parameters was tested for its signiﬁcance
Fig. 1 Parametric (#1 to #8,
#10) and categorical (#9, #11)
models used to investigate the
shape of the dose–responses
related to the risk that stems
from ionizing radiation. 1st row:
LNT model, quadratic model,
linear-quadratic model; 2nd
row: linear-exponential model,
linear threshold model
(sometimes only referred to as
threshold model, the threshold-
dose is denoted by Dth), step
model; 3rd row: step model with
slope, another step model with
slope, hormetic-like model; 4th
row: hormetic-like model with
slope; 3-step categorical model.
Note that in both hormetic-like
models the excess risk is set to
zero for D\0.005 Gy
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123resulting in a streamlined baseline model with 14 model
parameters less than the Preston baseline model, which also
lost its city dependence (see Table S2 in the Online
Resource). The streamlined baseline model no longer
contained four age at exposure dependences, three age
attained dependences, and the related ﬁve age knots. Fur-
thermore, it was found that the model ﬁt signiﬁcantly
improved when two other age knots were allowed to be
free (for details consult Sect. 2 of the Online Resource).
The streamlined baseline model for cardiovascular diseases
therefore has 15 (29 - 14) model parameters (see Table S2
in the Online Resource).
Fitting the descriptive risk models
After having acquired two streamlined baseline models for
CVD and cardiovascular diseases with the procedure
described in the previous two paragraphs, all other models
(i.e. models other than the LNT model that was already
used for the streamlining process) depicted in Fig. 1 were
also combined with the streamlined baseline models as
either ERR model or EAR model and ﬁtted to the data for
CVD and cardiovascular diseases. For those parametric and
categorical models that contain a threshold-dose Dth, the
following set of different values for Dth was used to care-
fully investigate which value leads to the smallest devi-
ance: 0.0001 Gy, 0.0002,…, 0.0005, 0.001, 0.005, 0.01,
0.02, …, 0.09, 0.1, 0.2, …, 0.9, 1, and 2 Gy. In the linear
threshold model, however, Dth was adjusted in the model
ﬁt. The step model was replaced by a modiﬁed hyperbolic
tangent function as described below. Throughout this
extensive approach, likelihood-ratio tests were applied to
compare nested models with each other, to eliminate those
nested models with inferior deviance values and to obtain
two ﬁnal sub-sets of non-nested models, one for each
detrimental health outcome.
The step model (Fig. 1) was not implemented as a cat-
egorical model. Instead, the following modiﬁed hyperbolic
tangent was used: 0.5 9 scale 9 [tanh(s(D - Dth)) ? 1].
With appropriate values for scale, slope s, and Dth, this
ﬂexible function can accommodate various entirely differ-
ent shapes, among them the step function as depicted in
Fig. 1 (model #3). With the hyperbolic tangent, steps are
not imposed a priori but are a result of a ﬁt to the data. The
advantage of this function is the fact that it generally allows
an estimate of Dth to be obtained with greater accuracy by
ﬁtting the model to data, while in a categorical implemen-
tation a value of Dth has to be assumed for each ﬁt.
It was also successively investigated whether or not any
of the three dose-effect modiﬁers, that is, sex, age attained,
and age at exposure improved the model ﬁts signiﬁcantly.
Data-ﬁtting techniques and MMI
The MECAN software (Kaiser 2010) was applied to ﬁt the
EAR and ERR models to the data. This software uses
Poisson regression (Scho ¨llnberger et al. 2006) to estimate
the values of the adjustable model parameters by ﬁtting the
model to the data. For the minimization of the Poisson
deviance, MECAN applies Minuit2 (2008). Symmetric,
Table 1 For both biological endpoints, the preferable ﬁnal non-
nested models are shown with related ﬁnal deviances (dev), difference
in ﬁnal deviances (Ddev) with respect to the model with the smallest
deviance, number of model parameters (Npar), AIC-values, difference
in AIC-values (DAIC) with respect to the model with the smallest
AIC-value, and Akaike weights
dev Ddev Npar AIC DAIC Weight
CVD (ICD-9 430–429)
ERR-LNT model [#1] 3569.51 3.46 22 3613.51 1.46 0.2628
ERR-quadratic model [#2] 3570.14 4.09 22 3614.14 2.09 0.1918
ERR-step model [#6], Dth = 0.62 Gy 3566.05 0 23 3612.05 0 0.5454
Preston’s ERR-LNT model 3599.58 33.53 30 3659.58 47.53 –
Cardiovascular diseases (390–429, 440–459)
EAR-LNT model
a [#1] 3693.73 0 17 3727.73 0 0.3619
ERR-quadratic model
a [#2] 3694.05 0.32 17 3728.05 0.32 0.1918
EAR-threshold model [#5], Dth = 2.0 Gy 3695.0 1.27 17 3729.0 1.27 0.1379
EAR-step model [#6], Dth = 2.19 Gy 3695.66 1.93 17 3729.66 1.93 0.3084
Preston’s ERR-LNT model 3709.71 15.98 30 3769.71 41.98 –
As a comparison, the values are also shown for Preston’s ERR-LNT models. Note that for cerebrovascular disease the three preferable models are
ERR models; for cardiovascular diseases, the four preferable non-nested models are EAR models. The numbers in brackets refer to the eleven
dose–responses depicted in Fig. 1
a Contains an age-dependent dose-effect modiﬁer
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estimates.
The ERR and EAR risk estimates are calculated directly
from the hazard function:
ERR ¼ð h=h0Þ 1
EAR ¼ h   h0:
ð1Þ
Conﬁdence intervals (CI) for the risk estimates given in
Eq. (A1) are calculated with Latin hypercube sampling
(LHS) which accounts for uncertainties and correlations of
all adjustable parameters. For a risk variable such as ERR,a
probability density distribution of 10
4 realizations is
generated, which is used to derive statistical descriptors
such as mean, median, and percentiles. The MECAN
software (Kaiser 2010) allows to perform Poisson
regression, comparison of observed and expected cases,
and simulation of uncertainty intervals within one run. The
software package and all model-related input and result
ﬁles are available from the authors upon request.
For both investigated detrimental health outcomes, the
ﬁnal non-nested models, which are presented in the
‘‘Results’’ section, were weighted according to the AIC
(see below) and used to perform MMI, which is a method
of mathematically superposing different non-nested models
that all describe a certain data set almost equally well
(Burnham and Anderson 2002). The method applies
Akaike’s Information Criterion (Akaike 1973, 1974):
AIC = dev ? 2 Npar, where Npar is the number of model
parameters. For each model ﬁt, an AIC-value is calculated.
For a set of n non-nested models, the Akaike weight, pm,i s
calculated for model m according to the following equation
(Claeskens and Hjort 2008):
pm ¼
exp  DAICm=2 ðÞ
Pn
j¼1 exp  DAICj=2
   : ð2Þ
Here, DAICm = AICm - AIC0, where AICm is the AIC-
value for model m and AIC0 is the smallest AIC-value of all
n models. The resulting weights, multiplied by a factor of
10
4, give the number of samples for risk estimates to be
generated by LHS simulations. Then, for each set of
preselected values of age attained, age at exposure, and
dose, the created model-speciﬁc probability density
functions (PDFs) are merged. The resulting probability
densityfunctions,eachofsize10
4,representalluncertainties
arising within a model and from the superposition of the
selectedmodels.Statisticalquantitiessuchasmean,median,
and percentiles are derived from the ﬁnal PDFs.
Below, larger deviances compared to our best models
(i.e. those with smallest AIC-values) are denoted by posi-
tive values of Ddev. The notation Dpar gives the difference
in number of parameters compared to the models with
smallest AIC.
Results
Using the approach outlined in the ‘‘Materials and methods’’
section, it was found that for CVD the following ﬁnal three
non-nested ERR models out-competed all other models and
were included in the sub-set for MMI: an ERR-LNT model
consisting of the streamlined baseline model with 21 sig-
niﬁcant baseline parameters combined with an LNT model
via parameter err (Ddev = 3.46; Table 1), an ERR-qua-
dratic model (Ddev = 4.09; Table 1), and an ERR-step
model with Dth = 0.62 Gy (Ddev = 0; Table 1 and
Fig. 1). Table 1 gives for these ﬁnal three non-nested
models all essential information obtained by ﬁtting them to
the CVD data. Table S1 in the Online Resource provides
all related model parameters and related best estimates
together with Wald-type standard errors: all three models
contain 21 baseline parameters; the ERR-LNT model and
the ERR-quadratic model each contain one radiation-rela-
ted parameter (err); the ERR-step model has two radiation-
related parameters (scale, Dth). As a comparison, Table 1
also includes the results for Preston’s ERR-LNT model:
Ddev = 33.53 and Dpar = 7, that is, even though Preston’s
ERR-LNT model has 7 parameters more than our ERR-
step model, the latter still leads to a better ﬁt than the
Preston model by 33.53 deviance points. This improvement
in ﬁt is related to the free age knots and age at exposure
knots described in the ‘‘Materials and methods’’ section.
For cardiovascular diseases, the MMI sub-set consisted
of four non-nested EAR models: an EAR-LNT model
(Ddev = 0), an EAR-quadratic model (Ddev = 0.32), an
EAR-threshold model with Dth = 2.0 Gy (Ddev = 1.27),
and an EAR-step model with Dth = 2.19 Gy (Ddev =
1.93). The ﬁrst two models both include a dose-effect
modiﬁer that depends on age attained. The step model was
implemented as a hyperbolic tangent function. Table 1
gives, for each of the ﬁnal four models, all essential
information obtained by ﬁtting them to the data for car-
diovascular diseases. Refer to Table S2 (Online Resource)
for all related model parameters (baseline and radiation
related), their best estimates and Wald-type standard errors.
It is noted that for younger ages the signiﬁcant dose-effect
modiﬁer in the EAR-LNT model leads to smaller slopes
than the one depicted in Fig. 3 (see Sect. 3 of the Online
Resource for details). As a comparison, Table 1 also
includes the results for Preston’s ERR-LNT model:
Ddev = 15.98 and Dpar = 13, that is, although Preston’s
ERR-LNT model has 13 parameters more than our EAR-
LNT model, the latter ﬁts the data for cardiovascular
diseases by 15.98 deviance points better than Preston’s
ERR-LNT model (Table 1).
The related AIC-values are shown in Table 1 together
with the Akaike weights pm (2). The latter were used to
perform MMI as described in the ‘‘Materials and methods’’
170 Radiat Environ Biophys (2012) 51:165–178
123section. The results are shown in Figs. 2 and 3. For CVD,
the deviance of 3566.57 (Ddev = 0.49) related to MMI is
easily obtained, since the dose–response contains no dose–
effect modiﬁers. The MMI predicts a very low ERR for
doses below the threshold, because of the contribution from
the ERR-step model with a threshold-dose of 0.62 Gy, and
the 95% CIs include zero risk (Table 2). Therefore, the
MMI risk estimates for CVD presented here are consistent
with zero risk below the threshold of 0.62 Gy. The results
for cardiovascular diseases follow a similar pattern: based
on the 90% CI, the MMI implies zero risk up to 2.24 Gy.
The striking improvements of the deviances presented
here compared with those from Preston’s ERR-LNT ﬁts
(Table 1) were mainly achieved by streamlining the base-
line models. Therefore, better matches of observed and
predicted cases were expected mainly in the group of
‘‘unexposed’’ survivors (i.e. individuals with doses below
5 mGy). To test this assumption, it was investigated which
categories of dose and age attained contribute most to the
decrease in deviance, found here with the preferred models,
when compared to Preston’s ERR-LNT ﬁts. For CVD, the
preferred model according to AIC is the ERR-step model,
for cardiovascular diseases it is the EAR-LNT model
(Table 1). Using the related best estimates from Tables S1
and S2, forward calculations were performed with the data
sets stratiﬁed into several groups of weighted colon dose
and age attained. For CVD in men, the strongest contri-
bution of 8.3 points to the improvement in deviance stems
from individuals in dose category 0.1\D B 0.5 Gy with
ages attained of 40 years and higher. For women, the
strongest contribution of 19.8 points is related to dose
categories 0.005\D B 0.1 Gy and 0.5\D B 1 Gy with
ages attained of 40 years and higher. For cardiovascular
diseases, the strongest contribution of 12 points stems from
women in dose categories 0.1\D B 0.5 Gy and
0.5\D B 1 Gy at ages of 60 and higher, while men
hardly improve the ﬁnal deviance compared to the ﬁt with
Preston’s ERR-LNT model (1915.21 versus 1915.88).
Detailed results can be seen in Tables S3, S4, and S5 in the
Online Resource.
For both detrimental health outcomes, the risk estimates
ERR and EAR were calculated for the multi-model infer-
ences and for the non-nested models listed in Table 1. The
results are given in Tables 2 and 3 for a dose of 1 Gy and
for different values of age attained (50 and 70 years) and
age at exposure. For CVD and cardiovascular diseases, the
mean age of the cases (i.e. of individuals who died from
these diseases) was about 77 and 78 years, respectively.
Because of the threshold at 0.62 Gy for CVD, for this
disease ERR and EAR were also calculated for 0.2 Gy. The
risk estimates from Preston et al. (2003) and Shimizu et al.
(2010) are also provided. For CVD, the EAR depends on
city and sex because it is calculated from ERR models and
because the streamlined baseline model presented here
depends on city and sex. Therefore, the EAR-values for
MMI and for the single models #1, #2, and #6 in Table 2
are only valid for men from Hiroshima. For cardiovascular
diseases, the ERR depends on sex because it is calculated
Fig. 2 ERR for cerebrovascular disease versus weighted colon dose
for the ﬁnal three non-nested ERR models and the multi-model
inference (MMI) (Table 1). Also shown are point estimates and
related 90% CI for a 3-step categorical ERR model that divides the
dose range into four categories: D\0.62 Gy, 0.62 Gy B D\1 Gy,
1G yB D\1.5 Gy, and D C 1.5 Gy. The 90% CI for the MMI are
provided in Table 2 for absorbed doses of 0.2 and 1 Gy. The ﬁgure is
valid for men and women of both cities. The preselected values for
age at exposure and age attained are 30 and 70 years, respectively
Fig. 3 EAR for cardiovascular diseases versus weighted colon dose
for the ﬁnal four non-nested EAR models and the multi-model
inference (refer to Table 1). Also shown are point estimates and
related 90% CI for a 3-step categorical ERR model that divides the
dose range into four categories: D\0.75 Gy, 0.75 Gy B D\1.5 Gy,
1.5 Gy B D\2.19 Gy, and D C 2.19 Gy. The 90% CI for the MMI
are provided in Table 3 for an absorbed dose of 1 Gy. The ﬁgure is
valid for men and women of both cities. The preselected values for
age at exposure and age attained are 30 and 70 years, respectively
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123from EAR models and because the applied streamlined
baseline model depends on sex (details are given in Sect. 5
of the Online Resource).
Discussion
In the present study, the dose–responses of the LSS non-
cancer mortality data for CVD and cardiovascular diseases
were investigated using different parametric and categori-
cal models (Fig. 1). Two sub-sets of ﬁnal, preferable, non-
nested models were identiﬁed, one for each detrimental
health outcome. These models are summarized in Table 1.
They all describe the data about equally well: only rela-
tively small differences in deviances and AIC-values were
found.
For CVD, the ERR-step model (model #6 in Fig. 1; with
the step smoothed by the hyperbolic tangent function) with
a threshold-dose of Dth = 0.62 Gy has the lowest AIC. The
LNT model and the quadratic model are also included in
the MMI (Fig. 2), resulting in a weak dose–response below
the threshold (with a risk estimate of about one-third of that
from the LNT model) and a stronger dose–response for
higher doses. MMI results in a small excess relative risk
below the threshold. The 90% conﬁdence intervals are
compatible with no risk up to 0.62 Gy (Table 2). This is
conﬁrmed by a ﬁt using a categorical model: the risk
estimate in the lowest dose group is not signiﬁcantly dif-
ferent from zero (Fig. 2).
An analogous argument holds for the analysis of the
LSS data for cardiovascular diseases (Fig. 3). Again, the
MMI does not contain any threshold-dose but the lower
bound of the related 90% CI at 1 Gy is zero (Table 3). The
MMI is in fact consistent with zero risk up to 2.24 Gy. In
that context, it is notable that a ﬁt with a categorical model
infers a U-shaped dose–response, that is, negative excess
Table 2 Values for ERR and EAR for cerebrovascular disease calculated with the multi-model inference, the ERR-LNT model, the ERR-
quadratic model, and the ERR-step model for 0.2 and 1 Gy and different values of age at exposure (e) and age attained (a)
ERR EAR [per 10
4 PY]
CVD
Multi-model inference
0.2 Gy
e = 20, a = 50 0.007 (0, 0.035) 0.05 (0, 0.23)
e = 20, a = 70 0.007 (0, 0.035) 0.17 (0, 0.84)
e = 30, a = 70 0.007 (0, 0.035) 0.3 (0, 1.4)
e = 50, a = 70 0.007 (0, 0.035) 0.8 (0, 3.8)
1G y
e = 20, a = 50 0.165 (0.033, 0.32) 1.10 (0.22, 2.1)
e = 20, a = 70 0.165 (0.033, 0.32) 3.97 (0.78, 7.7)
e = 30, a = 70 0.165 (0.033, 0.32) 6.6 (1.3, 13)
e = 50, a = 70 0.165 (0.033, 0.32) 18.0 (3.6, 35)
Single models
0.2 Gy, e = 30, a = 70
ERR-LNT model [#1] 0.0248 (0.0055, 0.044) 0.98 (0.22, 1.7)
ERR-quadratic model [#2] 2.84 9 10
-3 (4.0 9 10
-4, 5.3 9 10
-3) 0.114 (0.016, 0.21)
ERR-step model [#6], Dth = 0.62 Gy 0 0
1 Gy, e = 30, a = 70
ERR-LNT model [#1] 0.124 (0.028, 0.22) 4.9 (1.1, 8.7)
ERR-quadratic model [#2] 0.071 (0.010, 0.13) 2.85 (0.40, 5.3)
ERR-step model [#6], Dth = 0.62 Gy 0.22 (0.093, 0.34) 8.7 (3.7, 14)
Preston ERR-LNT model (Preston et al. 2003) 0.12 (0.02, 0.22) 5.0
a (1.0, 8.9)
ERR-LNT model (Shimizu et al. 2010) 0.09 (0.01, 0.17)
b 2.3 (0.4, 4.4)
b
The 90% conﬁdence intervals are provided. The risk values from Preston et al. (2003) and Shimizu et al. (2010) are also shown. The numbers in
brackets refer to the eleven dose–responses depicted in Fig. 1. The EAR-values for MMI and for the single models #1, #2, and #6 are only valid
for men in Hiroshima. The city-averaged EAR-values for men can be calculated by multiplication with a factor of 1.1 (see Sect. 6 of the Online
Resource for mathematical details). The EAR-values for women can be calculated by multiplying with a factor of 0.6
a Not given by Preston et al. (2003); calculated from Preston’s ERR-LNT model
b This is the 95% CI
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123absolute risk in the lower-dose regimes with a statistically
signiﬁcant negative risk in the lowest dose group (Fig. 3).
The increasing risk with attained age (via the age-depen-
dent dose-effect modiﬁer) produces a markedly higher risk
in the EAR-LNT model with 94 excess cases in contrast to
9 cases in the EAR-threshold model and the EAR-step
model, where the effect modiﬁer was not statistically sig-
niﬁcant. Consequently, the dose–response curve from MMI
also predicts a strongly reduced risk for death from car-
diovascular diseases due to radiation. In the context of the
results presented here, it is interesting to point out a recent
low-dose study in which ApoE null mice were used. This
mouse model system spontaneously develops atheroscle-
rosis when fed a normal low-fat diet. In these mice, the
effects of single doses of 25–500 mGy, given at either
early or late stage disease, were distinctly nonlinear with
dose and were generally protective for various measures of
the disease. In that animal model, most effects occurred
below about 100 mGy, and many of the endpoints mea-
sured showed maximum protective effects at 25-50 mGy
(Mitchel et al. 2011).
Related to Fig. 3, the EAR risk estimates for the EAR-
LNT model, the EAR-quadratic model and for the MMI
seem to be inconsistent with those calculated for the cat-
egorical ﬁt, especially at the lower three doses. It is
emphasized that this seeming inconsistency stems from the
signiﬁcant dose-effect modiﬁer in the EAR-LNT model
and the EAR-quadratic model (see Table S2 in the Online
Resource). Figure 3 relates to an age attained of 70 years.
For lower ages, the EAR-values for the EAR-LNT model
are markedly decreased (numerical details are provided
in Sect. 3 of the Online Resource). Consequently, this
reduction also decreases the EAR-values for the MMI.
It is noted that for both diseases the categorical model
(#11 in Fig. 1), a non-nested model, was not used for MMI
because of its negligible contributions to the AIC-weights
(Walsh 2007, Hoeting et al. 1999). Because of its similarity
to the shape implied by the categorical model ﬁt (Fig. 3),
we also used the Gompertz curve to ﬁt the excess absolute
risk associated with the data for cardiovascular diseases.
Again, it was found that the DAIC-based weight was too
small to be used for MMI. For details, see Sect. 7 of the
Online Resource.
Because of the well-known gender differences in car-
diovascular disease mortality (Roger et al. 2011), it was
investigated whether the data for men and women needed
to be ﬁtted separately. Model ﬁts of the data for men
and women were performed using an ERR-LNT model.
For CVD, some differences were noted for the slope
parameters (err = 0.109044 Gy
-1 for men versus err =
0.13524 Gy
-1 for women). However, comparing the rela-
ted ﬁnal deviances with the one from the joint ﬁt (Table 1:
dev = 3569.51 using 22 parameters) clearly showed that
ﬁtting the data for men and women separately does not lead
to a signiﬁcantly improved ﬁt (men: dev = 1779.58 using
11 parameters; women: dev = 1788.24 using 13 parameters;
sum = 3567.82). A similar result was found for cardio-
vascular diseases.
Preston et al. (2003) based their study on the use of the
following ﬁve models: an LNT model, a linear-quadratic
and a purely quadratic model, a linear threshold model, and
categorical models implemented as either ERR model or
EAR model. While Preston et al. (2003) report that there is
no direct evidence of radiation effects for doses less than
about 0.5 Sv, they conclude that radiation effects on LSS
non-cancer mortality can be adequately described by a
linear dose–response model. A data set on circulatory
disease mortality with 6 years of additional follow-up has
been publicly available since the end of 2010. Those data
were analysed recently by Shimizu et al. (2010) with the
Table 3 Values for ERR and EAR for cardiovascular diseases cal-
culated with the multi-model inference, the EAR-LNT model, the
EAR-quadratic model, the EAR-threshold model, and the EAR-step
model for 1 Gy and different values of age at exposure (e) and age
attained (a)
ERR EAR
[per 10
4 PY]
Cardiovascular diseases
Multi-model inference
e = 20, a = 50 0.10 (0, 0.35) 0.8 (0, 2.7)
e = 20, a = 70 0.12 (0, 0.35) 5 (0, 13)
e = 30, a = 70 0.09 (0, 0.25) 5 (0, 13)
e = 50, a = 70 0.07 (0, 0.18) 5 (0, 13)
Single models
e = 30, a = 70
EAR-LNT model [#1] 0.171
(0.078, 0.27)
8.8 (4.2, 14)
EAR-quadratic model [#2] 0.084 (0.026, 0.14) 4.4 (1.4, 7.4)
EAR-threshold model [#5],
Dth = 2.0 Gy
00
EAR-step model [#6],
Dth = 2.19 Gy
00
Preston’s ERR-LNT model,
Preston et al. (2003)
0.17
(0.08, 0.26)
9.1
a (4.2, 13.9)
ERR-LNT model,
Shimizu et al. (2010)
0.14
(0.06, 0.23)
b
3.2 (1.3, 5.2)
b
The 90% conﬁdence intervals are provided. The risk values from
Preston et al. (2003) and Shimizu et al. (2010) are also shown. The
numbers in brackets refer to the eleven dose–responses depicted in
Fig. 1. The ERR-values for MMI and for the single models #1, 2, 5,
and #6 are only valid for men. The ERR-values for women can be
calculated by multiplication with a factor of 1.8
a Not given by Preston et al. (2003); calculated from Preston’s ERR-
LNT model
b This is the 95% CI
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123LNT model and the linear threshold model (model #5 in
Fig. 1) for a wide range of possible values of threshold-
dose Dth. They used differences in maximum likelihood to
compare nested models and the AIC for non-nested mod-
els. For CVD, they report that the best estimate of a
threshold-dose was 0.5 Gy but that this value was not
statistically signiﬁcant so that no threshold-dose may exist.
For cardiovascular diseases, their best estimate of a
threshold-dose was 0 Gy (Shimizu et al. 2010). In the
present study, the earlier studies have been extended by
using several additional possible dose–responses and by
combining the results to obtain dose–responses and
uncertainty ranges that are not based on assumptions made
in a single model.
In their previous study, Preston et al. (2003) carefully
explain why they did not use the full available data with
follow-up starting in 1950. They state that characterization
of the dose–response is complicated by a healthy survivor
selection effect on non-cancer disease death rates. For a
few years after the bombings, baseline (zero dose) non-
cancer disease death rates for proximal survivors were
markedly lower than those for distal survivors. The dif-
ference diminished steadily over the ﬁrst two decades of
follow-up, by which time it had largely vanished. This
statistically signiﬁcant pattern suggests that proximal sur-
vivors included in the LSS were initially healthier than the
general population for reasons related to their selection by
having survived the bombings. Analyses of the LSS non-
cancer mortality data indicate that in 1950 baseline death
rates for proximal survivors were 15% lower than those for
distal survivors. The difference decreased to about 2% in
the late 1960s (Preston et al. 2003). It has been illustrated
by Preston et al. (2003) that a substantial healthy survivor
selection leads to spurious curvature in the dose–response.
According to Preston et al. (2003), the healthy survivor
effect can be dealt with by restricting the analyses to
proximal survivors and to the later period of follow-up, that
is, 1968–1997. Unfortunately, the latest analysis of the LSS
non-cancer data was done for the full cohort and for the full
period of follow-up, that is, 1950–2003 (Shimizu et al.
2010). Concern related to the fact that Shimizu et al. (2010)
place completely different emphasis and importance on the
reported magnitude of the healthy survivor bias has been
raised by Walsh (2011). Note that the downloadable
grouped data by Shimizu et al. (2010) do not contain the
same grouping boundaries as the data used in the present
study: there is no proximal/distal group and no boundary
corresponding to follow-up starting on 1 January 1968. A
preliminary analysis of exactly the same mortality data for
CVD that Shimizu et al. (2010) used (i.e. follow-up
1950–2003) using a streamlined Preston baseline model
showed that an ERR-LNT model is preferable. It is inter-
esting to note that when analysing the Shimizu CVD data
for the follow-up 1971-2003 (and thereby including most
of the original Preston et al. 2003 data plus the additional
6 years of follow-up plus the distal survivors), the present
authors found conﬁrmation for the threshold-dose of
0.6 Gy obtained in the current study. The Shimizu CVD
data for the follow-up 1971–2003 were analysed in the
same way as the Preston et al. (2003) data. The Preston
baseline model [Eq. (A1) of the Online Resource] was
combined with an ERR-LNT model and ﬁt to the data for
CVD. The Preston baseline model was then streamlined
using the likelihood-ratio test and then combined with the
step model from Fig. 1 as an ERR model. The related best
estimates and Wald-type standard errors (in parenthesis)
are as follows: Dth = 0.64 Gy (\1%), scale = 0.204
(0.081) with a ﬁxed value for the slope s:1 0
5/Gy (compare
with Table 1 in the Online Resource). However, because of
the above-mentioned incompatibility of the Shimizu et al.
(2010) data with the data used by Preston et al. (2003), the
analysis of the publicly available data set was not contin-
ued. Instead, the present authors are planning to pursue the
analysis of a more suitable data set with a time cut-point at
1 January 1968 and an added indicator to distinguish
proximal from distal survivors to be created by the Radi-
ation Effects Research Foundation (RERF) in Japan.
Application of the AIC criterion for model selection
exacts a rigorous application of parameter parsimony, since
model weights are very sensitive to differences in AIC. The
authors do not claim to have identiﬁed the optimal models.
There is a potential to detect better parameterizations by
ﬁtting nonparametric models to the baseline death rates.
However, the introduction of nonparametric baseline
models into MMI requires further theoretical investigations
by a larger number of experts. The present study leads to
streamlined fully parametric baseline models (with signif-
icantly lower deviances despite the smaller number of
model parameters) compared to the Preston baseline model
(Preston et al. 2003). However, the risk estimates presented
here with LNT models almost exactly correspond to those
of Preston et al. (2003) (Tables 2 and 3).
In addition to these observed threshold-doses, another
important difference from the earlier work of Preston et al.
(2003) and Shimizu et al. (2010) is that the analyses pre-
sented here for the radiation inﬂuence on cardiovascular
diseases actually favour EAR-risk models. The other
authors prefer ERR models but renounced the rigorous
application of quality-of-ﬁt criteria.
In a review of published low-/moderate-dose epidemi-
ological data sets on circulatory diseases, Little et al.
(2010) list in their Table 1 14 studies related to the
following exposed populations: atomic bomb survivors,
low- and moderate-dose therapeutically exposed groups,
diagnostically exposed groups, occupationally and envi-
ronmentally exposed groups. Here, the dose–response
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The two papers analysing LSS non-cancer data are by
Preston et al. (2003) and Yamada et al. (2004). The study
of Preston et al. (2003) made use of four different dose–
response models and has already been summarized above.
Yamada et al. (2004) assumed an additive linear dose–
response model: RRij = 1 ? bdij exp(ak(Zk)), where RRij is
the relative risk due to radiation dose associated with the
jth exposure level, dij is the jth dose level in stratum i, b is
the excess risk per Sievert averaged over all strata, and Zk
represents the effect modiﬁers (Yamada et al. 2004). They
also tested linear-quadratic and purely quadratic models.
For circulatory disease-related endpoints, such as hyper-
tension, ischaemic heart disease, myocardial infarction and
stroke, Yamada et al. (2004) did not ﬁnd a statistically
signiﬁcant dependence on radiation exposure. Little et al.
(2010) additionally included the following three studies
related to low-dose radiotherapy and medical diagnostics.
Carr et al. (2005) ﬁtted a generalized linear model to a
cohort of 3,719 peptic ulcer disease patients treated with
radiotherapy or by other means. In the studies by Darby
et al. (1987) and Davis et al. (1989), the standardized
mortality ratio (SMR; number of observed cases divided by
number of expected) as a precursor to modelling dose–
response curves was calculated. The following eight
occupational studies were also reviewed by Little et al.
(2010). Ashmore and colleagues analysed the mortality
from cancer and non-cancer diseases within a large cohort
of Canadian radiation workers comprising 206,620 indi-
viduals. They used a relative risk model with risk
increasing linearly with dose (Ashmore et al. 1998).
Azizova and Muirhead (2009) modelled the ERR in the
Mayak worker cohort by a linear trend with external or
internal dose. In their analysis of 61,017 Chernobyl
emergency workers, Ivanov et al. (2006) used a linear
dependence of risk on dose as did Kreuzer et al. (2010)i n
their analysis of cancer and cardiovascular diseases in the
German uranium miners cohort study. Non-cancer mor-
tality was analysed in a large cohort of employees in the
UK nuclear industry by McGeoghegan et al. (2008) using
the following model for ERR: R(b, a, r, i, s) = k(b, a, r, i, s)
[1 ? ERR(d)]. Here, R is the cause-speciﬁc mortality rate
and k is the background mortality rate in the absence of any
effects from radiation exposure. The subscripts b, a, r, i,
and s refer respectively to birth cohort, attained age, radi-
ation exposure status, employment status, and site of
employment. ERR(d) is a function of lagged cumulative
external dose (d) describing the excess relative risk
(McGeoghegan et al. 2008). Muirhead et al. (2009) per-
formed the latest analysis of the UK National Registry for
Radiation Workers comprising a total number of 174,541
persons. They analysed among other biological endpoints
the mortality from all circulatory diseases by modelling the
ERR as a linear function of dose. In their analysis of the
associations between low-level exposure and mortality
(including mortality from ischaemic heart disease) among
workers at Oak Ridge National Laboratory Richardson and
Wing (1999) applied a relative risk model of the form
k(Z, z, y) = exp(Za ? bx ? dy), where the mortality rate
(k) was considered in terms of a vector of covariates (Z),
the radiation dose accumulated before age 45 (x), and the
radiation dose accumulated after age 45 (y). This is a
generalized linear model. In the IARC 15-country study of
radiation workers, Vrijheid et al. (2007) found increasing
trends with dose for some biological endpoints and
decreasing trends for others, although none were statisti-
cally signiﬁcant. In that context, we point out that Vrijheid
et al. (2007) based their analyses on a linear relative risk
Poisson model, in which the relative risk is of the form
1 ? bZ, where Z is the lagged cumulative dose in Sv and b
is the excess relative risk per Sievert. Vrijheid et al. (2007)
state that this model has been used commonly in analyses
of nuclear workers studies and radiation risk estimation,
and reference ICRP (1991) and US NRC (2006). Detailed
results for the ERR found within these eight occupational
studies have been summarized by Little et al. (2010).
Talbott et al. (2003) reported a decreasing trend in heart
disease mortality with dose for men and women exposed as
a result of the accident at the Three Mile Island nuclear
power station. For women, the decreasing trend was
signiﬁcant. The authors performed logistic regression
ﬁtting multiplicative relative risk models of the form
k(t) = k0(t)exp(x(t)b) (i.e. a generalized linear model) to
the cohort rates (Talbott et al. 2003). This comprises the 14
studies reviewed by Little et al. (2010) including the study
on environmental exposure by Talbott et al. (2003). The
authors of the current study are convinced that dose–
response analyses and related risk estimations should not
be based on the application of only one model (for which
usually a linear increase of risk with increasing dose is
assumed) unless this one model is clearly preferred by
model selection techniques. In the present study, it has
been demonstrated that the use of a large variety of dose–
response curves leads to a better and more realistic
description of dose–response curves for non-cancer vas-
cular diseases than the use of LNT models.
MMI is a form of Bayesian model averaging (BMA;
Hoeting et al. 1999). It can be shown that the formula used
to perform BMA (Eq. 1 in Hoeting et al. 1999) reduces to
(2) for the Akaike weights pm when one assumes that
a priori all models are equally likely. This is the approach
chosen here with respect to the models shown in Fig. 1.
The present study did not aim to ﬁnd the true model but the
one which ﬁts the data best. In this case, Burnham and
Anderson (2002) (p. 77) argue for equal model priors (i.e.
equal prior probabilities for the models to be tested) under
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cism by Richardson and Cole (2012) of applying the MMI
technique in radiation epidemiology has been answered by
Walsh et al. (2011).
The present study showed that the application of the
MMI technique to non-cancer data of Report 13 on the
atomic bomb survivors leads to distinctly nonlinear dose–
response curves and related threshold-doses. This provides
strong evidence that low and medium doses of ionizing
radiation may have different effects than high doses. Such
ﬁndings may stimulate the development of mechanistic
models, which explain dose–responses based on radiobio-
logical cellular processes. Biologically based mechanistic
models are important for estimating at which stages of the
disease process radiation may act (see, for example, the
work of Little et al. (2009)). Motivated by the results of
the present analysis, it is promising to include into math-
ematical models biological mechanisms (such as, for
example, possible anti-inﬂammatory effects of low and
medium doses of ionizing radiations) that may lead to
distinct nonlinearities in the related dose–response curves.
How this works for the biological endpoint of cancer
induction after exposure to low doses of ionizing radiation
at low dose rates has been shown by Scho ¨llnberger et al.
(2004, 2005) using deterministic and stochastic multi-stage
models with clonal expansion.
Conclusions
Summarizing, it can be said that the present analyses of the
non-cancer mortality data from Report 13 on the atomic
bomb survivors predict a strongly reduced risk for death
from CVD and cardiovascular diseases excluding CVD due
to ionizing radiation. For CVD, MMI yielded a weak dose–
response (with a risk estimate of about one-third of the LNT
model) below a step at 0.6 Gy and a stronger dose–response
at higher doses. Based on 90% conﬁdence intervals, the
calculated risk estimates are consistent with zero risk below
this threshold-dose. Formortalities related tocardiovascular
diseases excluding CVD, an LNT-type dose–response was
found with risk estimates consistent with zero risk below
2.2 Gy based on 90% conﬁdence intervals. Great care must
be taken when analysing the shape of dose–responses for
non-cancer mortalities. In addition to LNT and linear
threshold models, other dose–responses must also be con-
sidered and tested. Non-standard dose–response curves
derived from the rigorous application of a statistical pro-
tocol may stimulate the development of mechanistic models
that explain dose–responses based on radiobiological cel-
lular processes. Analysing the shape of dose–responses by
testing a series of different empirical models, as it has been
done in the present study using MMI, provides valuable
information for the mechanistic modelling. In practical
radiation protection, MMI is an important tool for risk
assessment, especially at low doses. It allows different
models to be combined, leading to a more comprehensive
characterization of the uncertainty of risk estimates. This
conclusion also holds for other detrimental health effects
such as cancer.
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